Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice:
Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice:
Recruiting · NCT06322238 · Registry updated 2025-10-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice: | Drug Metabolism, Poor, CYP2C19-Related, Drug Metabolism, Poor, CYP2D6-Related | Recruiting | Phase 2 | 2025-10-14 | NCT06322238 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic | Rochester | United States | 68 |